Filtered By:
Source: Yonsei Medical Journal
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 373 results found since Jan 2013.
Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA < sub > 2 < /sub > DS < sub > 2 < /sub > -VASc Score 0-1: A Korean Multi-Center Cohort
CONCLUSION: The biomarker-based ABCD score demonstrated improved stroke risk stratification in AF patients with non-gender CHA2DS2-VASc score 0-1. Furthermore, NOAC with an ABCD score ≥1 was associated with significantly lower stroke rate in AF patients with non-gender CHA2DS2-VASc score 0-1.PMID:36168241 | PMC:PMC9520051 | DOI:10.3349/ymj.2022.0157
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Moonki Jung Kyeongmin Byeon Ki-Woon Kang Yae Min Park You Mi Hwang Sung Ho Lee Eun-Sun Jin Seung-Young Roh Jin Seok Kim Jinhee Ahn So-Ryoung Lee Eue-Keun Choi Min-Soo Ahn Eun Mi Lee Hwan-Cheol Park Ki Hong Lee Min Kim Joon Hyouk Choi Jum Suk Ko Jin Bae Ki Source Type: research
Didymin Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the PPAR Signaling Pathway
CONCLUSION: Didymin protected neuron cells against IR injury in vitro and in vivo by activation of the PPAR pathway. Didymin may be a candidate drug for IR treatment.PMID:36168249 | PMC:PMC9520049 | DOI:10.3349/ymj.2022.0040
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Qiang Li Hongting Zhang Xiumei Liu Source Type: research
Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA < sub > 2 < /sub > DS < sub > 2 < /sub > -VASc Score 0-1: A Korean Multi-Center Cohort
CONCLUSION: The biomarker-based ABCD score demonstrated improved stroke risk stratification in AF patients with non-gender CHA2DS2-VASc score 0-1. Furthermore, NOAC with an ABCD score ≥1 was associated with significantly lower stroke rate in AF patients with non-gender CHA2DS2-VASc score 0-1.PMID:36168241 | PMC:PMC9520051 | DOI:10.3349/ymj.2022.0157
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Moonki Jung Kyeongmin Byeon Ki-Woon Kang Yae Min Park You Mi Hwang Sung Ho Lee Eun-Sun Jin Seung-Young Roh Jin Seok Kim Jinhee Ahn So-Ryoung Lee Eue-Keun Choi Min-Soo Ahn Eun Mi Lee Hwan-Cheol Park Ki Hong Lee Min Kim Joon Hyouk Choi Jum Suk Ko Jin Bae Ki Source Type: research
Didymin Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the PPAR Signaling Pathway
CONCLUSION: Didymin protected neuron cells against IR injury in vitro and in vivo by activation of the PPAR pathway. Didymin may be a candidate drug for IR treatment.PMID:36168249 | PMC:PMC9520049 | DOI:10.3349/ymj.2022.0040
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Qiang Li Hongting Zhang Xiumei Liu Source Type: research
Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA < sub > 2 < /sub > DS < sub > 2 < /sub > -VASc Score 0-1: A Korean Multi-Center Cohort
CONCLUSION: The biomarker-based ABCD score demonstrated improved stroke risk stratification in AF patients with non-gender CHA2DS2-VASc score 0-1. Furthermore, NOAC with an ABCD score ≥1 was associated with significantly lower stroke rate in AF patients with non-gender CHA2DS2-VASc score 0-1.PMID:36168241 | PMC:PMC9520051 | DOI:10.3349/ymj.2022.0157
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Moonki Jung Kyeongmin Byeon Ki-Woon Kang Yae Min Park You Mi Hwang Sung Ho Lee Eun-Sun Jin Seung-Young Roh Jin Seok Kim Jinhee Ahn So-Ryoung Lee Eue-Keun Choi Min-Soo Ahn Eun Mi Lee Hwan-Cheol Park Ki Hong Lee Min Kim Joon Hyouk Choi Jum Suk Ko Jin Bae Ki Source Type: research
Didymin Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the PPAR Signaling Pathway
CONCLUSION: Didymin protected neuron cells against IR injury in vitro and in vivo by activation of the PPAR pathway. Didymin may be a candidate drug for IR treatment.PMID:36168249 | PMC:PMC9520049 | DOI:10.3349/ymj.2022.0040
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Qiang Li Hongting Zhang Xiumei Liu Source Type: research
Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA < sub > 2 < /sub > DS < sub > 2 < /sub > -VASc Score 0-1: A Korean Multi-Center Cohort
CONCLUSION: The biomarker-based ABCD score demonstrated improved stroke risk stratification in AF patients with non-gender CHA2DS2-VASc score 0-1. Furthermore, NOAC with an ABCD score ≥1 was associated with significantly lower stroke rate in AF patients with non-gender CHA2DS2-VASc score 0-1.PMID:36168241 | PMC:PMC9520051 | DOI:10.3349/ymj.2022.0157
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Moonki Jung Kyeongmin Byeon Ki-Woon Kang Yae Min Park You Mi Hwang Sung Ho Lee Eun-Sun Jin Seung-Young Roh Jin Seok Kim Jinhee Ahn So-Ryoung Lee Eue-Keun Choi Min-Soo Ahn Eun Mi Lee Hwan-Cheol Park Ki Hong Lee Min Kim Joon Hyouk Choi Jum Suk Ko Jin Bae Ki Source Type: research
Didymin Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the PPAR Signaling Pathway
CONCLUSION: Didymin protected neuron cells against IR injury in vitro and in vivo by activation of the PPAR pathway. Didymin may be a candidate drug for IR treatment.PMID:36168249 | PMC:PMC9520049 | DOI:10.3349/ymj.2022.0040
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Qiang Li Hongting Zhang Xiumei Liu Source Type: research
Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA < sub > 2 < /sub > DS < sub > 2 < /sub > -VASc Score 0-1: A Korean Multi-Center Cohort
CONCLUSION: The biomarker-based ABCD score demonstrated improved stroke risk stratification in AF patients with non-gender CHA2DS2-VASc score 0-1. Furthermore, NOAC with an ABCD score ≥1 was associated with significantly lower stroke rate in AF patients with non-gender CHA2DS2-VASc score 0-1.PMID:36168241 | PMC:PMC9520051 | DOI:10.3349/ymj.2022.0157
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Moonki Jung Kyeongmin Byeon Ki-Woon Kang Yae Min Park You Mi Hwang Sung Ho Lee Eun-Sun Jin Seung-Young Roh Jin Seok Kim Jinhee Ahn So-Ryoung Lee Eue-Keun Choi Min-Soo Ahn Eun Mi Lee Hwan-Cheol Park Ki Hong Lee Min Kim Joon Hyouk Choi Jum Suk Ko Jin Bae Ki Source Type: research
Didymin Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the PPAR Signaling Pathway
CONCLUSION: Didymin protected neuron cells against IR injury in vitro and in vivo by activation of the PPAR pathway. Didymin may be a candidate drug for IR treatment.PMID:36168249 | PMC:PMC9520049 | DOI:10.3349/ymj.2022.0040
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Qiang Li Hongting Zhang Xiumei Liu Source Type: research
Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA < sub > 2 < /sub > DS < sub > 2 < /sub > -VASc Score 0-1: A Korean Multi-Center Cohort
CONCLUSION: The biomarker-based ABCD score demonstrated improved stroke risk stratification in AF patients with non-gender CHA2DS2-VASc score 0-1. Furthermore, NOAC with an ABCD score ≥1 was associated with significantly lower stroke rate in AF patients with non-gender CHA2DS2-VASc score 0-1.PMID:36168241 | PMC:PMC9520051 | DOI:10.3349/ymj.2022.0157
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Moonki Jung Kyeongmin Byeon Ki-Woon Kang Yae Min Park You Mi Hwang Sung Ho Lee Eun-Sun Jin Seung-Young Roh Jin Seok Kim Jinhee Ahn So-Ryoung Lee Eue-Keun Choi Min-Soo Ahn Eun Mi Lee Hwan-Cheol Park Ki Hong Lee Min Kim Joon Hyouk Choi Jum Suk Ko Jin Bae Ki Source Type: research
Didymin Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the PPAR Signaling Pathway
CONCLUSION: Didymin protected neuron cells against IR injury in vitro and in vivo by activation of the PPAR pathway. Didymin may be a candidate drug for IR treatment.PMID:36168249 | PMC:PMC9520049 | DOI:10.3349/ymj.2022.0040
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Qiang Li Hongting Zhang Xiumei Liu Source Type: research
